Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Summit Therapeutics (SMMT) Asset Utilization Ratio (2017 - 2023)

Summit Therapeutics filings provide 7 years of Asset Utilization Ratio readings, the most recent being 0.0 for Q2 2023.

  • Quarterly Asset Utilization Ratio fell 95.36% to 0.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 0.0 through Jun 2023, down 95.36% year-over-year, with the annual reading at 0.0 for FY2022, 89.18% down from the prior year.
  • Asset Utilization Ratio hit 0.0 in Q2 2023 for Summit Therapeutics, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.85 in Q1 2019 and bottomed at 0.0 in Q2 2023.
  • Average Asset Utilization Ratio over 5 years is 0.07, with a median of 0.01 recorded in 2020.
  • The largest annual shift saw Asset Utilization Ratio plummeted 99.91% in 2019 before it skyrocketed 348.67% in 2022.
  • Summit Therapeutics' Asset Utilization Ratio stood at 0.03 in 2019, then crashed by 67.96% to 0.01 in 2020, then skyrocketed by 38.49% to 0.01 in 2021, then crashed by 88.49% to 0.0 in 2022, then plummeted by 48.05% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for SMMT's Asset Utilization Ratio are 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.0 (Q4 2022).